CORP — CORPORATE / INDUSTRY

Sanofi iAwards

Sanofi

This application window has closed. The entry is kept for reference — check the funder's page below for a future cycle. It is hidden from the index unless “Include past programs” is on.

Award

$150,000 seed + Sanofi scientific resources

Deadline

Annual call ~April; 2026 pre-proposals closed May 22

Award type

Cash grant

Focus

Basic science · Preclinical & therapeutics

Seed funding plus dedicated Sanofi expertise; around 40% of funded projects advance to multi-year sponsored research agreements. Open only to PIs at roughly 32 partner institutions including Stanford, Harvard, MIT, UCSF, Columbia, and Mass General Brigham.

Why it's in this index

The 2026 call sought innovative therapeutics for neuromuscular and cardio-muscular diseases addressing monogenic disorders through shared pathways including metabolism — a scope that covers BTHS cardiomyopathy and myopathy. The institutional restriction is the binding constraint.

Who can apply

Principal investigators at Sanofi's partner institutions only; partner status can be confirmed through an institution's tech-transfer or research office.

How to apply

Through your institution's research office when the annual call opens (~April); pre-proposals route via the institution. Contact: SRI-NA@sanofi.com.

Links & downloads

Sanofi iAwards ↗